Your browser doesn't support javascript.
loading
Decongestion discriminates risk for one-year mortality in patients with improving renal function in acute heart failure.
Wettersten, Nicholas; Horiuchi, Yu; van Veldhuisen, Dirk J; Ix, Joachim H; Mueller, Christian; Filippatos, Gerasimos; Nowak, Richard; Hogan, Christopher; Kontos, Michael C; Cannon, Chad M; Müeller, Gerhard A; Birkhahn, Robert; Taub, Pam; Vilke, Gary M; Duff, Stephen; McDonald, Kenneth; Mahon, Niall; Nuñez, Julio; Briguori, Carlo; Passino, Claudio; Maisel, Alan; Murray, Patrick T.
Afiliação
  • Wettersten N; Division of Cardiovascular Medicine, Veterans Affairs San Diego Healthcare System, San Diego, CA, USA.
  • Horiuchi Y; Division of Cardiovascular Medicine, University of California San Diego, La Jolla, CA, USA.
  • van Veldhuisen DJ; Division of Cardiology, Mitsui Memorial Hospital, Tokyo, Japan.
  • Ix JH; Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
  • Mueller C; Division of Nephrology-Hypertension, Department of Medicine, University of California San Diego and Veterans Affairs San Diego Healthcare System, San Diego, CA, USA.
  • Filippatos G; Department of Cardiology, University Hospital Basel, University of Basel, Basel, Switzerland.
  • Nowak R; Department of Cardiology, Athens University Hospital Attikon, University of Athens, Athens, Greece.
  • Hogan C; Department of Emergency Medicine, Henry Ford Hospital System, Detroit, MI, USA.
  • Kontos MC; Division of Emergency Medicine and Acute Care Surgical Services, VCU Medical Center, Virginia Commonwealth University, Richmond, VA, USA.
  • Cannon CM; Division of Cardiology, VCU Medical Center, Virginia Commonwealth University, Richmond, VA, USA.
  • Müeller GA; Department of Emergency Medicine, University of Kansas Medical Center, Kansas City, MO, USA.
  • Birkhahn R; Department of Nephrology and Rheumatology, University Medical Center Göttingen, University of Göttingen, Göttingen, Germany.
  • Taub P; Department of Emergency Medicine, New York Methodist, Brooklyn, NY, USA.
  • Vilke GM; Division of Cardiovascular Medicine, University of California San Diego, La Jolla, CA, USA.
  • Duff S; Department of Emergency Medicine, University of California San Diego, La Jolla, CA, USA.
  • McDonald K; School of Medicine, University College Dublin, Dublin, Ireland.
  • Mahon N; Department of Cardiology, Mater Misericordiae University Hospital, University College Dublin, Dublin, Ireland.
  • Nuñez J; Department of Cardiology, St. Vincent's University Hospital, Dublin, Ireland.
  • Briguori C; Department of Cardiology, Mater Misericordiae University Hospital, University College Dublin, Dublin, Ireland.
  • Passino C; Department of Cardiology, Hospital Clínico Universitario Valencia, INCLIVA, University of Valencia, Valencia, Spain.
  • Maisel A; CIBER in Cardiovascular Diseases, Madrid, Spain.
  • Murray PT; Department of Cardiology, Interventional Cardiology, Mediterranea Cardiocentro, Naples, Italy.
Eur J Heart Fail ; 23(7): 1122-1130, 2021 07.
Article em En | MEDLINE | ID: mdl-33788989
ABSTRACT

AIMS:

Improving renal function (IRF) is paradoxically associated with worse outcomes in acute heart failure (AHF), but outcomes may differ based on response to decongestion. We explored if the relationship of IRF with mortality in hospitalized AHF patients differs based on successful decongestion. METHODS AND

RESULTS:

We evaluated 760 AHF patients from AKINESIS for the relationship between IRF, change in B-type natriuretic peptide (BNP), and 1-year mortality. IRF was defined as a ≥20% increase in estimated glomerular filtration rate (eGFR) relative to admission. Adequate decongestion was defined as a ≥40% decrease in last measured BNP relative to admission. IRF occurred in 22% of patients who had a mean age of 69 years, 58% were men, 72% were white, and median admission eGFR was 49 mL/min/1.73 m2 . IRF patients had more severe heart failure reflected by lower admission eGFR, higher blood urea nitrogen, lower systolic blood pressure, lower sodium, and higher use of inotropes. IRF patients had higher 1-year mortality (25%) than non-IRF patients (15%) (P < 0.01). However, this relationship differed by BNP trajectory (P-interaction = 0.03). When stratified by BNP change, non-IRF patients and IRF patients with decreasing BNP had lower 1-year mortality than either non-IRF and IRF patients without decreasing BNP. However, in multivariate analysis, IRF was not associated with mortality [adjusted hazard ratio (HR) 1.0, 95% confidence interval (CI) 0.7-1.5] while BNP was (adjusted HR 0.5, 95% CI 0.3-0.7). When IRF was evaluated as transiently occurring or persisting at discharge, again only BNP change was significantly associated with mortality.

CONCLUSION:

Improving renal function is associated with mortality in AHF but not independent of other variables and congestion status. Achieving adequate decongestion, as reflected by lower BNP, in AHF is more strongly associated with mortality than IRF.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Insuficiência Cardíaca Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Humans / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Insuficiência Cardíaca Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Humans / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article